THE PAST few months have been particularly tumultous for Jaiprakash. The 44-year-old resident of Delhi is infected with HIV or the human immunodeficiency virus, for which there is no cure or no vaccine. So Jaiprakash, like most other HIV patients an estimated 40 million people are living with HIV globally, as per the World Health Organization (WHO)-depends on a cocktail of drugs to supress the viral load in his blood. The drugs, known as antiretroviral therapy (ART), delay the progression of the infection into acquired immunodeficiency syndrome (AIDS) and result in fatal consequences. In June, Jaiprakash's doctor changed his treatment regimen to help him better fight the infection. But the art centre run by the National aids Control Office (NACO) for providing free medicines, diagnostic kits and other essentials for those in need, did not have stocks of the prescribed drugs. "Of the three drugs prescribed, the healthcare provider at the art centre gave me only abacavir and lamivudine, that too the paediatric versions. I now take 10 tablets a day instead of one," Jaiprakash tells Down To Earth (DTE). To obtain the third drug, dolutegravir, which who recommends as the "preferred first-line treatment" because of high efficacy and fewer side-effects, Jaiprakash took a desperate step in July.
"Through our support network I learnt that an HIV patient at Delhi's Lok Nayak Jai Prakash Narayan Hospital, who was on the same treatment regimen, died. His drugs were thrown in the garbage bin and I retrieved them," he says.
Jaiprakash knows that the drugs retrieved from the garbage are not going to last long. So since July 21, he has joined about 40 other HIV and AIDS patients in protesting the shortage of ART drugs at NACO's office in New Delhi.
Denne historien er fra August 16, 2022-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra August 16, 2022-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.